96 related articles for article (PubMed ID: 33220287)
1. Pseudogene PA2G4P4 promotes oncogene PA2G4 expression and nuclear translocation to affect glioblastoma cell viability and apoptosis.
Hou X; Tang W
Life Sci; 2021 Jan; 265():118793. PubMed ID: 33220287
[TBL] [Abstract][Full Text] [Related]
2. PA2G4P4 Promotes Glioma Cell Migration and Tumorigenesis through the PTEN/AKT/mTOR Signaling Pathway.
Hou X; Kou Z; Zhang H
J Environ Pathol Toxicol Oncol; 2023; 42(2):1-9. PubMed ID: 36749086
[TBL] [Abstract][Full Text] [Related]
3. Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis.
Pisapia L; Terreri S; Barba P; Mastroianni M; Donnini M; Mercadante V; Palmieri A; Verze P; Mirone V; Altieri V; Califano G; Liguori GL; Strazzullo M; Cimmino A; Del Pozzo G
Biology (Basel); 2020 Mar; 9(4):. PubMed ID: 32244410
[TBL] [Abstract][Full Text] [Related]
4. LINC00987 knockdown inhibits the progression of acute myeloid leukemia by suppressing IGF2BP2-mediated PA2G4 expression.
Liu C; Ma Y; Wang R; Su G
Anticancer Drugs; 2022 Jan; 33(1):e207-e217. PubMed ID: 34407052
[TBL] [Abstract][Full Text] [Related]
5. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
Ni H; Ji D; Huang Z; Li J
Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294
[TBL] [Abstract][Full Text] [Related]
6. Pseudogene ANXA2P2 knockdown shows tumor-suppressive function by inhibition of the PI3K/PKB pathway in glioblastoma cells.
Ni H; Zhi R; Zuo J; Liu W; Xie P; Zhi Z
J Biochem Mol Toxicol; 2021 Aug; 35(8):e22824. PubMed ID: 34047431
[TBL] [Abstract][Full Text] [Related]
7. YY1-Activated Long Noncoding RNA SNHG5 Promotes Glioblastoma Cell Proliferation Through p38/MAPK Signaling Pathway.
Chen L; Gong X; Huang M
Cancer Biother Radiopharm; 2019 Nov; 34(9):589-596. PubMed ID: 31657621
[No Abstract] [Full Text] [Related]
8. Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface.
Koach J; Holien JK; Massudi H; Carter DR; Ciampa OC; Herath M; Lim T; Seneviratne JA; Milazzo G; Murray JE; McCarroll JA; Liu B; Mayoh C; Keenan B; Stevenson BW; Gorman MA; Bell JL; Doughty L; Hüttelmaier S; Oberthuer A; Fischer M; Gifford AJ; Liu T; Zhang X; Zhu S; Gustafson WC; Haber M; Norris MD; Fletcher JI; Perini G; Parker MW; Cheung BB; Marshall GM
Cancer Res; 2019 Nov; 79(21):5652-5667. PubMed ID: 31501192
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA-RNCR3 overexpression deleteriously affects the growth of glioblastoma cells through miR-185-5p/Krüppel-like factor 16 axis.
Zhang L; Cao Y; Wei M; Jiang X; Jia D
J Cell Biochem; 2018 Nov; 119(11):9081-9089. PubMed ID: 29953649
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CASP5 promotes the malignant phenotypes of human glioblastoma multiforme.
Zhou Y; Dai W; Wang H; Pan H; Wang Q
Biochem Biophys Res Commun; 2018 Jun; 500(4):966-972. PubMed ID: 29715460
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
[TBL] [Abstract][Full Text] [Related]
13. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
14. Integrative genomic analyses identify WDR12 as a novel oncogene involved in glioblastoma.
Li JL; Chen C; Chen W; Zhao LF; Xu XK; Li Y; Yuan HY; Lin JR; Pan JP; Jin BL; Li FC
J Cell Physiol; 2020 Oct; 235(10):7344-7355. PubMed ID: 32180229
[TBL] [Abstract][Full Text] [Related]
15. Depletion of thymopoietin inhibits proliferation and induces cell cycle arrest/apoptosis in glioblastoma cells.
Zhang L; Wang G; Chen S; Ding J; Ju S; Cao H; Tian H
World J Surg Oncol; 2016 Oct; 14(1):267. PubMed ID: 27756319
[TBL] [Abstract][Full Text] [Related]
16. miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma.
Zuo J; Yu H; Xie P; Liu W; Wang K; Ni H
Gene; 2019 Aug; 710():233-239. PubMed ID: 31181312
[TBL] [Abstract][Full Text] [Related]
17. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
[TBL] [Abstract][Full Text] [Related]
18. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF
Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108
[TBL] [Abstract][Full Text] [Related]
19. A structural view of PA2G4 isoforms with opposing functions in cancer.
Stevenson BW; Gorman MA; Koach J; Cheung BB; Marshall GM; Parker MW; Holien JK
J Biol Chem; 2020 Nov; 295(47):16100-16112. PubMed ID: 32952126
[TBL] [Abstract][Full Text] [Related]
20. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
